APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Josamycin Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Josamycin Tablets Market Outlook and Growth Opportunities 2026

Report ID 174005420426 December 2025199 pages

Choose your research edition.

Industry ResearchJosamycin Tablets Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Josamycin Tablets Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Josamycin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Josamycin Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Josamycin Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Josamycin Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Josamycin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Josamycin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Josamycin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Josamycin Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Josamycin Tablets market include Shanghai Sine Pharmaceutical, Harbin Pharmaceutical Group, Guilin Nantang Pharmaceutical, Guangzhou Baiyunshan Guanghua Pharmaceutical, Astellas Pharma and CSPC OUYI PHARMACEUTICAL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Josamycin Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Josamycin Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Josamycin Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Josamycin Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Josamycin Tablets Segment by Company

Shanghai Sine Pharmaceutical

Harbin Pharmaceutical Group

Guilin Nantang Pharmaceutical

Guangzhou Baiyunshan Guanghua Pharmaceutical

Astellas Pharma

CSPC OUYI PHARMACEUTICAL

Josamycin Tablets Segment by Type

200mg

50mg

Josamycin Tablets Segment by Application

Hospital

Clinic

Others

Josamycin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Josamycin Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Josamycin Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Josamycin Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Josamycin Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Josamycin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Josamycin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Josamycin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Josamycin Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Josamycin Tablets industry.

Chapter 3: Detailed analysis of Josamycin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Josamycin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Josamycin Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Josamycin Tablets Industry Trends Table 2. Josamycin Tablets Industry Drivers Table 3. Josamycin Tablets Industry Opportunities and Challenges Table 4. Josamycin Tablets Industry Restraints Table 5. Global Josamycin Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Josamycin Tablets Revenue Share by Company (2021-2026) Table 7. Global Josamycin Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Josamycin Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Josamycin Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Josamycin Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Josamycin Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Josamycin Tablets Company, Product Type & Application Table 13. Global Josamycin Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Josamycin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 200mg Table 18. Significant Companies of 50mg Table 19. Global Josamycin Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Josamycin Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Josamycin Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Josamycin Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Josamycin Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Josamycin Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Josamycin Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Josamycin Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Josamycin Tablets Sales Value Share by Type (2021-2026) Table 28. Global Josamycin Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Josamycin Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Josamycin Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Josamycin Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Josamycin Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Josamycin Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Josamycin Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Josamycin Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Josamycin Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Josamycin Tablets Sales Value Share by Application (2021-2026) Table 41. Global Josamycin Tablets Sales Value Share by Application (2027-2032) Table 42. Global Josamycin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Josamycin Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Josamycin Tablets Sales Market Share by Region (2021-2026) Table 45. Global Josamycin Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Josamycin Tablets Sales Market Share by Region (2027-2032) Table 47. Global Josamycin Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Josamycin Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Josamycin Tablets Sales Value Share by Region (2021-2026) Table 50. Global Josamycin Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Josamycin Tablets Sales Value Share by Region (2027-2032) Table 52. Global Josamycin Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Josamycin Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Josamycin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Josamycin Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Josamycin Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Josamycin Tablets Sales Market Share by Country (2021-2026) Table 58. Global Josamycin Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Josamycin Tablets Sales Market Share by Country (2027-2032) Table 60. Global Josamycin Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Josamycin Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Josamycin Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Josamycin Tablets Sales Value Market Share by Country (2027-2032) Table 64. Shanghai Sine Pharmaceutical Company Information Table 65. Shanghai Sine Pharmaceutical Business Overview Table 66. Shanghai Sine Pharmaceutical Josamycin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Shanghai Sine Pharmaceutical Josamycin Tablets Product Portfolio Table 68. Shanghai Sine Pharmaceutical Recent Development Table 69. Harbin Pharmaceutical Group Company Information Table 70. Harbin Pharmaceutical Group Business Overview Table 71. Harbin Pharmaceutical Group Josamycin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Harbin Pharmaceutical Group Josamycin Tablets Product Portfolio Table 73. Harbin Pharmaceutical Group Recent Development Table 74. Guilin Nantang Pharmaceutical Company Information Table 75. Guilin Nantang Pharmaceutical Business Overview Table 76. Guilin Nantang Pharmaceutical Josamycin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Guilin Nantang Pharmaceutical Josamycin Tablets Product Portfolio Table 78. Guilin Nantang Pharmaceutical Recent Development Table 79. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information Table 80. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview Table 81. Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Product Portfolio Table 83. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development Table 84. Astellas Pharma Company Information Table 85. Astellas Pharma Business Overview Table 86. Astellas Pharma Josamycin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Astellas Pharma Josamycin Tablets Product Portfolio Table 88. Astellas Pharma Recent Development Table 89. CSPC OUYI PHARMACEUTICAL Company Information Table 90. CSPC OUYI PHARMACEUTICAL Business Overview Table 91. CSPC OUYI PHARMACEUTICAL Josamycin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. CSPC OUYI PHARMACEUTICAL Josamycin Tablets Product Portfolio Table 93. CSPC OUYI PHARMACEUTICAL Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Josamycin Tablets Distributors List Table 97. Josamycin Tablets Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Josamycin Tablets Product Image Figure 2. Global Josamycin Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Josamycin Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Josamycin Tablets Sales (2021-2032) & (K Units) Figure 5. Global Josamycin Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Josamycin Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 200mg Image Figure 10. 50mg Image Figure 11. Global Josamycin Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Josamycin Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Josamycin Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Josamycin Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Josamycin Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Josamycin Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Josamycin Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Josamycin Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Josamycin Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Josamycin Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Josamycin Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Josamycin Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Josamycin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Josamycin Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Josamycin Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Josamycin Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Josamycin Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Josamycin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Josamycin Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Josamycin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Josamycin Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Josamycin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Josamycin Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Josamycin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Josamycin Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Josamycin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Josamycin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Josamycin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Josamycin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Josamycin Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Josamycin Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg
  • 50mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Shanghai Sine Pharmaceutical
  • Harbin Pharmaceutical Group
  • Guilin Nantang Pharmaceutical
  • Guangzhou Baiyunshan Guanghua Pharmaceutical
  • Astellas Pharma
  • CSPC OUYI PHARMACEUTICAL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Josamycin Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Josamycin Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Josamycin Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Josamycin Tablets Market Dynamics
  1. 2.1 Josamycin Tablets Industry Trends
  2. 2.2 Josamycin Tablets Industry Drivers
  3. 2.3 Josamycin Tablets Industry Opportunities and Challenges
  4. 2.4 Josamycin Tablets Industry Restraints
3 Josamycin Tablets Market by Company
  1. 3.1 Global Josamycin Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Josamycin Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Josamycin Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Josamycin Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Josamycin Tablets Company Ranking (2024-2026)
  6. 3.6 Global Josamycin Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Josamycin Tablets Company Product Type and Application
  8. 3.8 Global Josamycin Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Josamycin Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Josamycin Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Josamycin Tablets Market by Type
  1. 4.1 Josamycin Tablets Type Introduction
  2. 4.1.1 200mg
  3. 4.1.2 50mg
  4. 4.2 Global Josamycin Tablets Sales Volume by Type
  5. 4.2.1 Global Josamycin Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Josamycin Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Josamycin Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Josamycin Tablets Sales Value by Type
  9. 4.3.1 Global Josamycin Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Josamycin Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Josamycin Tablets Sales Value Share by Type (2021-2032)
5 Josamycin Tablets Market by Application
  1. 5.1 Josamycin Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Josamycin Tablets Sales Volume by Application
  6. 5.2.1 Global Josamycin Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Josamycin Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Josamycin Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Josamycin Tablets Sales Value by Application
  10. 5.3.1 Global Josamycin Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Josamycin Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Josamycin Tablets Sales Value Share by Application (2021-2032)
6 Josamycin Tablets Regional Sales and Value Analysis
  1. 6.1 Global Josamycin Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Josamycin Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Josamycin Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Josamycin Tablets Sales by Region (2027-2032)
  5. 6.3 Global Josamycin Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Josamycin Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Josamycin Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Josamycin Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Josamycin Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Josamycin Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Josamycin Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Josamycin Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Josamycin Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Josamycin Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Josamycin Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Josamycin Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Josamycin Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Josamycin Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Josamycin Tablets Sales Value Share by Country, 2025 VS 2032
7 Josamycin Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Josamycin Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Josamycin Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Josamycin Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Josamycin Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Josamycin Tablets Sales by Country (2027-2032)
  6. 7.4 Global Josamycin Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Josamycin Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Josamycin Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Josamycin Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Josamycin Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Josamycin Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Josamycin Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Josamycin Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Josamycin Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Josamycin Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Josamycin Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Josamycin Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Josamycin Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Josamycin Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Josamycin Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Josamycin Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Josamycin Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Josamycin Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Josamycin Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Josamycin Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Josamycin Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Josamycin Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Josamycin Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Josamycin Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Josamycin Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Josamycin Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Josamycin Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Josamycin Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Josamycin Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Josamycin Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Josamycin Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Josamycin Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Josamycin Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Sine Pharmaceutical
  2. 8.1.1 Shanghai Sine Pharmaceutical Company Information
  3. 8.1.2 Shanghai Sine Pharmaceutical Business Overview
  4. 8.1.3 Shanghai Sine Pharmaceutical Josamycin Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Sine Pharmaceutical Josamycin Tablets Product Portfolio
  6. 8.1.5 Shanghai Sine Pharmaceutical Recent Developments
  7. 8.2 Harbin Pharmaceutical Group
  8. 8.2.1 Harbin Pharmaceutical Group Company Information
  9. 8.2.2 Harbin Pharmaceutical Group Business Overview
  10. 8.2.3 Harbin Pharmaceutical Group Josamycin Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Harbin Pharmaceutical Group Josamycin Tablets Product Portfolio
  12. 8.2.5 Harbin Pharmaceutical Group Recent Developments
  13. 8.3 Guilin Nantang Pharmaceutical
  14. 8.3.1 Guilin Nantang Pharmaceutical Company Information
  15. 8.3.2 Guilin Nantang Pharmaceutical Business Overview
  16. 8.3.3 Guilin Nantang Pharmaceutical Josamycin Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Guilin Nantang Pharmaceutical Josamycin Tablets Product Portfolio
  18. 8.3.5 Guilin Nantang Pharmaceutical Recent Developments
  19. 8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical
  20. 8.4.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  21. 8.4.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
  22. 8.4.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Product Portfolio
  24. 8.4.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
  25. 8.5 Astellas Pharma
  26. 8.5.1 Astellas Pharma Company Information
  27. 8.5.2 Astellas Pharma Business Overview
  28. 8.5.3 Astellas Pharma Josamycin Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Astellas Pharma Josamycin Tablets Product Portfolio
  30. 8.5.5 Astellas Pharma Recent Developments
  31. 8.6 CSPC OUYI PHARMACEUTICAL
  32. 8.6.1 CSPC OUYI PHARMACEUTICAL Company Information
  33. 8.6.2 CSPC OUYI PHARMACEUTICAL Business Overview
  34. 8.6.3 CSPC OUYI PHARMACEUTICAL Josamycin Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CSPC OUYI PHARMACEUTICAL Josamycin Tablets Product Portfolio
  36. 8.6.5 CSPC OUYI PHARMACEUTICAL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Josamycin Tablets Value Chain Analysis
  2. 9.1.1 Josamycin Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Josamycin Tablets Sales Mode & Process
  6. 9.2 Josamycin Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Josamycin Tablets Distributors
  9. 9.2.3 Josamycin Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst